Efficacy of once-yearly zoledronic acid 5 mg in men with osteoporosis with different levels of serum total testosterone
Steven Boonen(KU Leuven), Eric Orwoll(Oregon Health & Science University), Oscar Antúnez, Hans Peter Dimai(Medical University of Graz), Kurt Lippuner(University of Bern), Dirk Vanderschueren(KU Leuven), Bente Langdahl(Aarhus University Hospital), Erik Fink Eriksen(Osteoporosis Canada), Jean‐Marc Kaufman(Ghent University Hospital), René Rizzoli(University Hospital of Geneva), Josef Hruska(Novartis (Switzerland)), Guoqin Su(Novartis (Switzerland)), Kim Brixen, Jean‐Yves Reginster(University of Liège), José Zanchetta(Universidad del Salvador)
Open Repository and Bibliography (University of Liège)
January 1, 2012
Cited by 0
Related Papers
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2001|4.6k
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2009|3.5k
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
|New England Journal of Medicine|2014|1.2k
Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial
|The Lancet|2009|837
Gut microbiome pattern reflects healthy ageing and predicts survival in humans
|Nature Metabolism|2021|668